For instance, the formation of fibrosis, the vasculitis, and the production of autoantibodies in SSc patients are shown to be affected by the circulating levels of the TGF-β- and/or ET-1-related markers [10]. The gene discussed is TGFB1; the disease is systemic sclerosis.